C, L., H, Z., P, L., J, T., Y, H., L, Y., & T, S. (2026). TLR9 agonists alleviate diabetic condition by promoting the maturation of differentiated bone marrow mesenchymal stem cells in rats. Pakistan journal of pharmaceutical sciences, 39(7), 2173. https://doi.org/10.36721/PJPS.2026.39.7.205.1
Chicago Style (17th ed.) CitationC, Liu, Zheng H, Lu P, Tian J, Hu Y, Yao L, and Sun T. "TLR9 Agonists Alleviate Diabetic Condition by Promoting the Maturation of Differentiated Bone Marrow Mesenchymal Stem Cells in Rats." Pakistan Journal of Pharmaceutical Sciences 39, no. 7 (2026): 2173. https://doi.org/10.36721/PJPS.2026.39.7.205.1.
MLA (9th ed.) CitationC, Liu, et al. "TLR9 Agonists Alleviate Diabetic Condition by Promoting the Maturation of Differentiated Bone Marrow Mesenchymal Stem Cells in Rats." Pakistan Journal of Pharmaceutical Sciences, vol. 39, no. 7, 2026, p. 2173, https://doi.org/10.36721/PJPS.2026.39.7.205.1.